BOSTON SCIENTIFIC CORPORATION Supplier Finance Program Obligation Increase
BOSTON SCIENTIFIC CORPORATION (BSX) reported Supplier Finance Program Obligation Increase of $698.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Payables and Accruals
us-gaap:SupplierFinanceProgramObligationIncrease · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION supplier finance program obligation increase for fiscal 2025 was $698.00M, a 5.12% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION supplier finance program obligation increase for fiscal 2024 was $664.00M.
| Period end | Supplier Finance Program Obligation Increase 12 month |
|---|---|
| 2025-12-31 | $698.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $664.00M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |